Results 11 to 20 of about 70,747 (277)

A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-Injector. [PDF]

Neurol Ther, 2022
Farej R, Rametta M, La Rose A, Quillen A, McLeod K.   +4 more
europepmc   +3 more sources

Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome [PDF]

Therapeutic Advances in Neurological Disorders, 2014
The BEtaferon®/BEtaseron® in Newly Emerging MS For Initial Treatment (BENEFIT) trial assessed the efficacy of early versus delayed treatment with interferon beta-1b for patients with clinically isolated syndrome (CIS).
Mark S. Freedman
doaj   +2 more sources

Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial. [PDF]

Clin Infect Dis, 2023
Tam AR, Zhang RR, Lung KC, Liu R, Leung KY, Liu D, Fan Y, Lu L, Lam AH, Chung TW, Yip CC, Lo J, Wu AK, Lee R, Sin S, Ng PY, Chan WM, Shum HP, Yan WW, Chan JF, Cheng VC, Lau CS, To KK, Chan KH, Yuen KY, Hung IF.   +25 more
europepmc   +3 more sources

Phylogenetic and In Silico Analysis of Interferon Beta-1b Protein

Journal of Mazandaran University of Medical Sciences, 2017
Background and purpose: Interferon beta-1b recombinant protein is used for reducing the relapse rate and treatment in patients with Multiple sclerosis (MS).
Ziaeddin Mirhoseini, Zahra Pezeshkian, Shahrokh Ghovvati   +2 more
doaj   +1 more source

Why interferon beta 1b was licensed is a mystery [PDF]

BMJ, 1996
EDITOR,—Patients with multiple sclerosis are interested in whether they can still go to work, get out of bed to go to the lavatory, or stand on one leg to put the other one through their pants—that is to say, they are interested in disability. Interferon beta …
Peter Harvey
openaire   +4 more sources

Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients. [PDF]

Brain Behav, 2020
Hänninen K, Jääskeläinen O, Herukka SK, Soilu-Hänninen M.   +3 more
europepmc   +2 more sources

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial [PDF]

Lancet, The, 2020
Kwok-Cheung Lung, Tom Wai-Hin Chung, Hoi-Ping Shum   +2 more
exaly   +2 more sources

Preventing Aggregation of Recombinant Interferon beta-1b in Solution by Additives: Approach to an Albumin-Free Formulation. [PDF]

Adv Pharm Bull, 2015
Mahjoubi N, Fazeli MR, Dinarvand R, Khoshayand MR, Fazeli A, Taghavian M, Rastegar H.   +6 more
europepmc   +3 more sources

Interferon Beta-1B

, 2020
National Cancer Institute
openaire   +2 more sources

Excision of interferon beta-1b-associated plate-like secondary osteoma cutis [PDF]

JAAD Case Reports
Karenna Sandoval, BS, David Carey, MD
doaj   +2 more sources